Micro Cap Insider
Major Run on (HBRM) Herborium Group, Maker of Rosacea, AcnEase & ME-Mask
Published
4 years agoon
By
Boe RimesHBRM () has skyrocketed up the charts in recent months out of the triple zeroes to recent highs of $0.0072. The stock has been under heavy accumulation recently and volume has picked up substantially since Microcapdaily first covered the stock in December regularly trading billions of shares and several million dollars in daily trading volume. After some recent choppy waters HBRM Investors are looking for a break over $0.0072 highs and confirmation of the next leg up and a powerhouse blue sky breakout on HBRM as so many penny stocks are these days fueled by robinhood and its 100 million new trading accounts take on the bulletin boards. These are different times than just a few short years ago; now penny stocks such as TSNP can achieve a $6 billion plus market valuation and trade $375 million in dollar volume in a day on the bulletin boards. And TSNP has no stronger fundamentals than HBRM does.
There is a lot to get excited about on HBRM; The Company has a strong team behind it and is led by its founder, high level biotech exec Agnes Olszewski, PhD, founding partner of ClearSign Diagnostics (CSD) and holding 66% preferred A shares of HBRM. Other founders are partner CSD James Gilligan who is also co-founder of Osteon therapeutics. HBRM management is quickly becoming known for running a very tight ship and for doing things the right way; HBRM is virtually debt free, with a very clean balance sheet and no big notes. Revenues have been growing steadily; HBRM reported (just under a million USD) $993,000 in revenues for fiscal 2020, ended November 30. The Company has a low cost of sales and reported $639,000 in gross income and a net income of $47,000. Unheard of numbers on the otc bulletin boards. HBRM flagship AcnEase® has helped over three quarter of a million women and men of every age and skin tone to achieve healthy skin and healthy self–perception. In December 2020 Herborium launched the first product line extension which is complementary to its Botanical Therpeutic®- AcnEase®. This product focused on acne scars, marks and other cosmetic imperfections of the skin. The product line utilizes plant-based stem cell technology developed by NASA. The product series is already a part of the Asian expansion plan and is the first module in introducing the AcnEase Skin Management System. Additional products in the space are already being reviewed. HBRM recently signed a master distribution agreement with Phinix Global Pte. Ltd; is a part of GPS Alliance Holdings Limited (AU:GPS) which is listed on the Sydney Stock Exchange. GPS has extensive reach throughout South East Asia. In addition to marketing and distributing Herborium’s products Herborium and GPS are presently discussing additional near-term partnerships to foster growth in the US and Asia. Phinix is presently in the process of registering Herborium’s products in Singapore to make them ready for a rollout in Asian markets in the second quarter of 2021. Earlier this month HBRM launched its antimicrobial, anti-viral, water repellent (Prevents Aerosol Viral Transmission), reusable fabric face mask. The mask provides protection for yourself and those around you by preventing COVID-19 transmission The Herborium ME-Mask is based on proprietary Japanese technology and has been tested by Intertek, a Total Quality Assurance provider based in the UK that provides Assurance, Testing, Inspection and Certification services in over 100 countries. Herborium’s ME-Masks are differentiated from any other standard cloth masks on the market, by their internationally confirmed ability to protect the user as well as others. Through their 2 -in -One double layer innovative technology they show 99.98% Reduction Water Repellant and retain its beneficial qualities for 30 washes.
HBRM) Herborium Group, Inc. is a botanical therapeutics® company that develops, licenses and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. HBRM flagship AcnEase® has helped over three quarter of a million women and men of every age and skin tone to achieve healthy skin and healthy self–perception. The Company’s business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.
Herborium secured a pipeline of botanical ingredient based products in the areas of dermatological needs, Prostate Health (BPH), Liver Diseases, Women’s Health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, surgical procedures, and other problems. The longer-term pipeline includes arthritis candidate and the anti-infectious product candidate focused on antibiotic resistant infections. Herborium Managements represents a unique blend of expertise with over 50 years of successful business dealings in Asia, an exceptional track record in pharmacology and drug development, clinical testing and regulatory affairs in the US and Europe, supported by high standards, know how in herbal science and formulation, and specifically Modern Chinese Medicine.
Herborium presently sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. With initial seed investment brought to the Company by Friends and Family and a small professional round, spear-headed by Southridge Investment Group LLC, the Company is ideally positioned for exponential growth in the near future.
Microcapdaily reported on HBRM on December 7 as the stock was moving up out of the triple zeroes stating: “HBRM is moving up the charts in recent weeks as the Company is becoming current on OTCMarkets with the recent filing of a number of quarters including for the period ending August 31, 2020. The stock is quickly attracting a fast growing shareholder base who continues to heavily accumulate. HBRM is making money off its acne product AcnEase recently reporting a net income in the past 3 quarters with revenues of $260,000 for the 3 months ended August 31, 2020. The Company has very little debt and no big notes on the books and states on its website its longer-term pipeline includes arthritis candidate and the anti-infectious product candidate focused on antibiotic resistant infections. The Company has a strong team behind it and is led by its founder, high level biotech exec Agnes Olszewski, PhD, founding partner of ClearSign Diagnostics (CSD) and holding 66,7% preferred A shares of HBRM. Other founding partner CSD James Gilligan holds 33,3% pref A of HRBM and is also co founder of Osteon therapeutics.
On January 8 Agnes Olszewski, HBRM CEO stated in an update: “Despite the impact of Covid-19 and associated ‘lockdowns’, Herborium® financial results actually where significantly improved. Our revenues grew 13% in comparison to 2019, with gross margin increased 14.75%. We ended 2020 with profitable 3rd and 4th quarters and an approximately 2/3rd decrease in our short term debt; all this was achieved without any changes to the capitalization table (i.e. no dilution) or other outside resources. Our major European distribution partner THG (LON), a British e-commerce company went public on London Stock Exchange and is fast becoming one of the world’s leading beauty and wellbeing online retailer. We are prepared to participate in this growth through our ongoing commercial relationship which we hope to expand in the coming year.
As the global dietary supplements market is poised to grow by $26.7 billion during the period spanning 2020-2024, the major shift lies in where this growth will come from. In 2017, 31% of the world’s consumer disposable income originates from Asia. By 2030, Asia is expected to add an additional USD12 trillion in disposable income, which is almost 55% of the global increment. The Asian skincare market is expected to grow by 6% by 2022. To harness this opportunity, in November 2020 Herborium ®signed a master distribution agreement with Phinix Global Pte. Ltd. (“Phinix”). Phinix Global Pte. Ltd. is a part of GPS Alliance Holdings Limited (AU:GPS) which is listed on the Sydney Stock Exchange. GPS has extensive reach throughout South East Asia . In addition to marketing and distributing Herborium’s products Herborium and GPS are presently discussing additional near term partnerships to foster growth in the US and Asia. Phinix is presently in the process of registering Herborium’s products in Singapore to make them ready for a rollout in Asian markets in the second quarter of 2021.
Our unique botanicals based acne, Rosacea and oily skin treatment AcnEase® has helped over three quarter of a million women and men of every age and skin tone to achieve healthy skin and healthy self–perception. However, one product is not enough to justify the growth we want to secure for the company. In December 2020 Herborium launched the first product line extension which is complementary to our Botanical Therpeutic®- AcnEase® . This product focused on acne scars, marks and other cosmetic imperfections of the skin. The product line utilizes plant based stem cell technology developed by NASA. The product series is already a part of the Asian expansion plan and is the first module in introducing the AcnEase Skin Management System. Additional products in the space are already being reviewed. To keep up with new technological and regulatory opportunities in the US and globally we intend to capitalize on new ingredients such as terpenes and cannabinoids as critical ingredients in the development of these new products.”
Investor sentiment in HBRM is very high:
$HBRM… Ive been holding since day one. No where near its potentials!
— EC Green Days (@ecgreendays) February 16, 2021
$hbrm, don't forget they issued convertible shares at 30 cents, buy this and hold, simple as that! https://t.co/D9YxWJFg9Q
— Josh (@JustMyViews1111) February 20, 2021
To Find out the inside Scoop on HBRM Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
On February 8 HBRM launched an antimicrobial, anti-viral, water repellent (Prevents Aerosol Viral Transmission), reusable fabric face mask. The mask will provide protection for yourself and those around you by preventing COVID-19 transmission www.memasklife.com. The Herborium ME-Mask is based on proprietary Japanese technology and has been tested by Intertek www.intertek.com , a Total Quality Assurance provider based in the UK that provides Assurance, Testing, Inspection and Certification services in over 100 countries.
Herborium’s ME-Masks are differentiated from any other standard cloth masks on the market, by their internationally confirmed ability to protect the user as well as others. Through their 2 -in -One double layer innovative technology they show 99.98% Reduction Water Repellant and retain its beneficial qualities for 30 washes. The inner layer of the mask uses colloidal copper and colloidal silver known for their antimicrobial and anti-viral properties to enhance the protective value of the mask. Herborium masks also provide superb comfort for prolonged use and are created to prevent and mitigate mask acne.. Consumer’s cost is less than $0.70 per use since Herborium feels responsible to make the product available to a large number of consumers and customers. Herborium expects to sell the masks using its own e-commerce platform and through the network of existing and new distributors and partners in the US and abroad. According to Polaris Market Research the Face Mask Market will surpass $31.83 Billion by 2027 | CAGR: 24.6%. With 50% of the US population expected to wear masks at this time next year, the fastest growth in face mask market is expected in the sector of reusable, personal masks which are projected to surpass $9 billion in revenues by the end of 2021. This calculation is based on a rather conservative assumption that each consumer will buy only 5 multi use masks (according to Keybanc Capital Markets).
HBRM CEO Dr. Agnes P. Olszewski stated: “We expect to generate additional, sizable revenues through the sales of our proprietary new masks, while at the same time expanding our product line and reach to existing and potential new consumers suffering from such skin problems as acne and Rosacea (www.acnease.com). ME-Mask not only offers superb protection against the spread of Covid-19. It is also created to mitigate the occurrence of a new, emerging type of acne, mask acne (maskne) resulting from prolonged wear of facial covering. Providing an important solution to problems facing consumers while growing the company, improving our bottom line and building our brand name is a very beneficial path both – short term and for the company’s future.” concluded Dr Olszewski.
If you’re wondering why $HBRM is spiking, this is what you need to know. Their partner “THG” is worth over $6 billion dollars, they’re also in the process of becoming current”$OPTI $DSGT $ENZC $TSNP $SEGI $CBDD $ABQQ $PRPM $PTTN $NECA $SNDL $MRNJ $ARCS $SFOR $ALPP $AEPT $WDLF pic.twitter.com/urUapFtjBv
— Angry Red (@AngryRed316) December 24, 2020
For more on HBRM Subscribe Right Now!
HBRM has skyrocketed up the charts in recent months out of the triple zeroes to recent highs of $0.0072. The stock has been under heavy accumulation recently and volume has picked up substantially since Microcapdaily first covered the stock in December regularly trading billions of shares and several million dollars in daily trading volume. After some recent choppy waters HBRM Investors are looking for a break over $0.0072 highs and confirmation of the next leg up and a powerhouse blue sky breakout on HBRM as so many penny stocks are these days fueled by robinhood and its 100 million new trading accounts take on the bulletin boards. These are different times than just a few short years ago; now penny stocks such as TSNP can achieve a $6 billion plus market valuation and trade $375 million in dollar volume in a day on the bulletin boards. And TSNP has no stronger fundamentals than HBRM does. There is a lot to get excited about on HBRM; The Company has a strong team behind it and is led by its founder, high level biotech exec Agnes Olszewski, PhD, founding partner of ClearSign Diagnostics (CSD) and holding 66% preferred A shares of HBRM. Other founders are partner CSD James Gilligan who is also co-founder of Osteon therapeutics. HBRM management is quickly becoming known for running a very tight ship and for doing things the right way; HBRM is virtually debt free, with a very clean balance sheet and no big notes. Revenues have been growing steadily; HBRM reported (just under a million USD) $993,000 in revenues for fiscal 2020, ended November 30. The Company has a low cost of sales and reported $639,000 in gross income and a net income of $47,000. Unheard of numbers on the otc bulletin boards. HBRM flagship AcnEase® has helped over three quarter of a million women and men of every age and skin tone to achieve healthy skin and healthy self–perception. In December 2020 Herborium launched the first product line extension which is complementary to our Botanical Therpeutic®- AcnEase®. This product focused on acne scars, marks and other cosmetic imperfections of the skin. The product line utilizes plant-based stem cell technology developed by NASA. The product series is already a part of the Asian expansion plan and is the first module in introducing the AcnEase Skin Management System. Additional products in the space are already being reviewed. HBRM recently signed a master distribution agreement with Phinix Global Pte. Ltd; is a part of GPS Alliance Holdings Limited (AU:GPS) which is listed on the Sydney Stock Exchange. GPS has extensive reach throughout South East Asia. In addition to marketing and distributing Herborium’s products Herborium and GPS are presently discussing additional near-term partnerships to foster growth in the US and Asia. Phinix is presently in the process of registering Herborium’s products in Singapore to make them ready for a rollout in Asian markets in the second quarter of 2021. HBRM sees big things happening this year “2021 will see the unveiling of the new content and content platform utilizing artificial intelligence and cross industry partnerships that will make Herborium attractive not only to the global consumers and customers but also to major social media and medical and wellness services providers. Earlier this month HBRM launched its antimicrobial, anti-viral, water repellent (Prevents Aerosol Viral Transmission), reusable fabric face mask. The mask provides protection for yourself and those around you by preventing COVID-19 transmission The Herborium ME-Mask is based on proprietary Japanese technology and has been tested by Intertek, a Total Quality Assurance provider based in the UK that provides Assurance, Testing, Inspection and Certification services in over 100 countries. Herborium’s ME-Masks are differentiated from any other standard cloth masks on the market, by their internationally confirmed ability to protect the user as well as others. Through their 2 -in -One double layer innovative technology they show 99.98% Reduction Water Repellant and retain its beneficial qualities for 30 washes. We will be updating on HBRM when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with HBRM.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: we hold no position in HBRM either long or short and we have not been compensated for this article.
Featured
Clean Vision Corp (OTC: CLNV): Overcoming the Plastic Waste Crisis
Published
11 months agoon
January 18, 2024Clean Vision Corporation (OTC: CLNV) has experienced several interesting developments recently, but it hasn’t noticeably influenced the market with any substantial gains. Nonetheless, we believe it’s worth providing an update on the company given it’s been a few months since our last mention. In today’s discussion, we’ll explore a variety of updates and their significance, with aim of providing insight on what to expect for 2024.
Background:
Clean Vision is led by Dan Bates, and their goal is to tackle the global plastic waste crisis head-on. Their wholly owned subsidiary, Clean Seas, has developed the Plastic Conversion Network (PCN), a groundbreaking technology aimed at diverting millions of tons of waste plastic from landfills, incineration, and oceans. The PCN converts this plastic feedstock into clean fuels and green hydrogen, significantly reducing reliance on fossil fuels and lowering the carbon footprint.
For a brief 2 minute overview on the company, feel free to reference the video CLNV’s subsidiary put together on YouTube. Here’s the link.
Clean Seas utilizes proven pyrolysis technology to produce environmentally friendly products, which are sold to multinational petrochemical companies, driving the circular plastic economy. Operational PCN facilities are already in place in Morocco and India, with additional conversion facilities in development across West Virginia, Arizona, and Southeast Asia. Long-term feedstock supply agreements exceeding one million tons of waste plastic annually have been secured at no cost.
Their recently trademarked brand, AquaH®, is produced in their PCN. According to the release, it offers a differentiated green hydrogen product from carbon-neutral sources. Currently, hydrogen is predominantly produced through methods that involve fossil fuels, which of course contributes to global carbon emissions. Furthermore according to Deloitte’s 2023 global green hydrogen outlook, this could be a $1.4T annual market by 2050.
$65 Million Plastic Conversion Facility:
CLNV is making big moves in West Virginia and according to the release on October 24th, 2023, they’ve brought in some serious players—CDI Engineering Solutions and ERM—to help out with their Clean-Seas West Virginia project.
CDI has over 70 years of experience integrating engineering, design, project support, procurement and construction management services to the energy, chemicals and electrical infrastructure markets.
ERM is the world’s largest advisory firm focused solely on sustainability, offering environmental, health, safety, risk and social expertise for more than 50 years with more than 8,500 dedicated professionals operating across 40 countries.
The plan is to kick things off in 2024, turning 100 tons of plastic every day into recycled plastics and clean fuels. It’s a hefty project with a $65 million investment, creating over 200 jobs initially. And they’re not stopping there—they want to scale up to 500 tons of plastic per day over time.
West Virginia Governor Jim Justice is also on board, throwing over $12 million in state incentives to support the project.
Governor Jim Justice made a reference to Clean Seas in his state of the union address. If you want to catch the mention, go to 34:15 in the video. The three minutes leading up to it are also worth reviewing.
Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Launches Global Operations:
CLNV made another significant advancement, planning to launch waste plastic conversion facilities in the European Union, Eastern Europe, and Southeast Asia. This will be accomplished through their new subsidiary, Clean-Seas Partners UK Limited (CS-UK), who of course shares the same vision of creating sustainable solutions to the global plastic pollution crisis.
Under the leadership of Managing Director Shaun Wootton, CS-UK will play a crucial role in strategic project development and investment facilitation, leveraging established relationships in the Middle East, Southeast Asia, and Europe.
To fortify effective governance and strategic direction, CS-UK is assembling a distinguished board with internationally recognized figures in banking, sustainability, and energy. This approach aims to have a diverse and experienced board guiding CS-UK in realizing its vision of promoting sustainability and environmental stewardship across diverse regions.
$340 Million Bond Offering:
CLNV even announced they partnered with a global advisory firm, Grant Thornton, to issue up to $340 million in Green Bonds. This is the world’s sixth-largest network of independent accounting and consulting firms, employing 62,000 people in more than 130 countries and had revenues of $6.6 billion in 2021. These bonds will fund the expansion of Clean Vision’s Plastic Conversion Network (PCN) under the “Clean-Seas” initiative worldwide, aimed at combatting plastic pollution on a global scale.
With the Green Bond’s net proceeds, CLNV plans to deploy at least six plastic waste conversion lines globally, with strategic locations in West Virginia, Arizona, Southeast Asia, and expansion in Morocco. The Green Bond is also expected to attract environmentally conscious investors, setting a new standard for corporate responsibility.
$15M Government Loan:
Lastly, under the capable management of Huntington Bank, CLNV has recently secured a $15 million government loan. What sets this apart is that the loan is FORGIVABLE.
A forgivable loan is a type of loan where the borrower is not required to repay the borrowed amount under certain conditions. Typically, these conditions are related to the borrower meeting specific criteria, such as using the funds for approved purposes, maintaining certain employment levels, or achieving predetermined goals. If the borrower fulfills these conditions, the loan is forgiven, and they are not obligated to repay the borrowed amount. Forgivable loans are often used as an incentive or support for specific activities, such as job creation, small business development, or other initiatives that contribute to economic growth or community welfare.
Not to mention it won’t result in any dilution for shareholders. This is an unexpected and uncommon accomplishment for an OTC company. Securing a government loan of this size without any dilution is truly impressive.
Conclusion:
CLNV has made impressive strides tackling the global plastic waste crisis, especially given their valuation of merely $22.65 million. The team has swiftly achieved key objectives, including a $65 million plastic conversion facility in West Virginia, global expansion through Clean-Seas Partners UK Limited, a $340 million Green Bond Offering, and a remarkable $15 million forgivable government loan. The vast $1.4 trillion market they’re tapping into offers an interesting opportunity with current indicators looking positive. Nevertheless, it’s crucial to acknowledge that there is still significant work ahead, and the team needs to maintain consistent execution to turn this potential into a reality.
We will update you on CLNV when more details emerge, subscribe to Microcapdaily to follow along!
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.
Picture by pasja1000 from Pixabay
Featured
Meta Materials (NASDAQ: MMAT): More Due Diligence and Exploring Latest Developments
Published
11 months agoon
January 16, 2024Meta Materials (NASDAQ: MMAT) witnessed a significant uptick in trading activity on January 16th, 2024, resulting in a notable 20% increase in its stock value by market close. Intrigued by this surge, we explored various sources, including press releases, SEC filings, and social media, to identify the catalyst behind this sudden gain.
Unexpectedly our research revealed no recent material releases. Instead, the surge seems tied to an announcement from a few days ago that didn’t grab much attention at first. As time passed, it started generating more buzz but there’s still a lot more to dig into and a number of ideas to consider for today’s rally.
If you haven’t caught up on our previous analyses of MMAT, you can find the overview here. In this report, we aim to explore the cause-and-effect dynamics of recent events, offering insights that might illuminate expectations for Meta Materials in the near future.
Background:
If you’re new to MMAT or haven’t been a long-time follower, let’s kick things off with a quick intro to the company.
Meta Materials stands at the forefront of advanced materials and nanotechnology. Their focus is on pioneering novel products and technologies utilizing sustainable and innovative scientific approaches. The interesting part is their advanced materials have the transformative power to enhance a variety of common products, infusing them with heightened intelligence and sustainability.
Leveraging its technology platforms, they’re capable of empowering global brands in creating cutting-edge products that elevate overall performance.
Their technology has application across multiple industries including aerospace and defense, consumer electronics, 5G communications, batteries, authentication, automotive, and clean energy. Their agreement with Panasonic is certainly a great start to empowering their growth in one of many verticals. Overall the TAM is ~$32B and with current growth rates, it’ll increase to a whopping ~$61B by 2026.
MMAT’s goal is to shape a smarter and more sustainable world. If you look through their presentation, you can continue to evaluate the many ways their technology transforms everyday lives. We highly suggest you take a look.
Additional Resources:
- @LauraLoomer’s video on MMAT
- @metaheadj’s post on X, displaying Rob Stone‘s response update for an investor
Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
What Happened:
So, MMAT issued a press release on January 11th, 2024, announcing a proposed settlement with the Securities and Exchange Commission (SEC) concerning an investigation related to the Torchlight Energy Resources, Inc. and Metamaterial Inc. merger.
According to the release, The company has extended a settlement offer (Proposed SEC Settlement) to the SEC’s Division of Enforcement. This proposed settlement aims to address concerns regarding antifraud, reporting, books and records, and internal accounting control provisions of securities laws. It is important to note that the Proposed SEC Settlement is contingent on approval by the SEC Commissioners, and the company cannot predict the approval timeline.
If accepted, the Proposed SEC Settlement would involve the SEC entering a cease-and-desist order and the company paying a civil money penalty of $1 million over a one-year period in four installments. Notably, the company would neither admit nor deny the findings outlined in the Order.
The company’s board of directors and management team view the Proposed SEC Settlement as beneficial for shareholders. If approved, it is expected to remove uncertainty surrounding the investigation, enabling the company to focus on advancing its business objectives.
So What:
If you’ve just read through the announcement and are confused, you’re not alone. It appears that many investors may have mis-read the press release, thinking that the SEC was being punished and MMAT was reaching a settlement agreement, but it appears to be the other way around.
In the event of approval, the company is obligated to pay a civil money penalty of $1 million. This penalty would be paid in four installments over the course of one year, following an agreed-upon payment plan. However, the PR also notes that the company cannot predict with certainty whether or when the Proposed SEC Settlement will even be approved by the SEC Commissioners.
According to another user on X, @AShortSqueeze, MMAT’s initial analysis has potentially revealed the motherload of counterfeit shares.
But if you scroll through the comments, you’ll see other users pointing out that this information is actually old news. This is just one of many widely circulated posts that might have been misunderstood.
Significant Coverage:
Another theory suggests that a notable influencer in the financial space, @MoonMarket_, has set their sights on the company and is conducting additional due diligence. With a substantial following of almost 75K users, the influencer’s involvement could have contributed to a significant fluctuation in today’s trading session. It’s important to recognize that X is packed with plenty of financial influencers, and blindly following their moves can be risky. Many are involved in day trades, momentum trading, or at least contemplating such strategies.
Conclusion:
The buzz around MMAT today seems fuelled by a mix of misrepresented themes and recycled news, creating the illusion of fresh, imminent developments.
As per usual, the magnitude of MMAT’s technology and potential integrations across various verticals continues to create a roar of excitement. On another front, we’re also continuing to see speculation about a short squeeze due to substantial amounts of counterfeit shares.
For now, patience is key and we suggest closely monitoring developments. MMAT especially tends to be quite volatile.
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.
Picture by StartupStockPhotos from Pixabay
Featured
Integrated Cannabis Solutions’ (OTC: IGPK) 633% Surge: Exploring Catalysts, Company Overview, and Growth Potential in 2024
Published
11 months agoon
January 12, 2024Integrated Cannabis Solutions (OTC: IGPK) has undergone a remarkable uptrend, surging an impressive 633% since December 11th, 2023, with 166% of that surge taking place across yesterday’s trading session and today, January 11th, 2023. Both days have been marked by unprecedented volume – Yahoo Finance reported an almost 30x increase, with 115,867,027 shares traded by close yesterday. We’re already seeing 90,092,317 shares traded this morning and it’s just barely noon. Today we’ll explore the catalysts behind the surge, offer a comprehensive overview of the company, and evaluate IGPK’s potential for sustained growth throughout 2024.
Background:
Let’s get straight to it. IGPK is the result of a recent reverse merger with Integrated Cannabis Solutions and JFH Digital E-Commerce Corp. The first thing you’ll notice is finding the website isn’t a walk in the park, we’re fairly certain there isn’t one yet, at least one that will help in any way related to more investment information. Your best bet for more any information is to check out IGPK’s OTC Market page for details, but even the company description on there is not accurate. We’ve mainly found the following information through filings, IGPK’s Twitter, and other online users.
Keep in mind this breakdown might not be flawless given we’re piecing it together mostly from what folks on X are saying. But we’ll try our absolute best to lay it all out for you.
IGPK appears to have been a shell for little while until JFH stepped in. A user on X, @stockplayer30, broke it down fairly simply, stating that the shell’s slate was wiped clean, cancelling all notes payable and any debt. Whether it’s a promissory note, convertible note, or convertible debenture, the main point is they ditched all debt. JFH has an opportunity to start fresh, and it certainly makes this deal a lot more interesting.
Just a heads up, it’s a Chinese merger. If the idea of a Chinese leadership team makes you a bit wary, you might want to pause here. However if you were in the trading game during the summer of ’23, you probably remember those crazy spikes in some Chinese Nasdaq deals. And get this – no big press releases or SEC filings to explain those sudden jumps either.
Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Company Description:
Onto what the company actually does. According to @SuperRobotOTC on X, this is a digital e-commerce company based in China, here’s a link to their e-commerce website. This user also put together a great overview of the company on YouTube, if you’d like to watch something informative in video format, click here.
Another user, @igal_n, found a blurb on the company that states, “Junfenghuang (JFH) is a digital asset. It is a token issued by Uplus Future Company with the help of blockchain technology. It has no direct relationship with the original equity”.
The Potential:
What makes this story extremely interesting is the sheer magnitude of how large JFH is, the intrinsic value does not appear to be valued accurately in the market, given it’s only freshly merged into IGPK’s tiny shell company on the OTC.
Their Gross Merchandise Value (GMV) is heading north of 50 billion yuan, and post-merger profits from service outlets are looking at a hefty 10 billion yuan – yes, billion with a B.
Steering the ship is a leadership team featuring President Wang Dejun, Treasurer Xie Weiji, and Director Yang Lanfang. With a whopping 750 subsidiaries, 250,000 merchants, and 30 million registered users. We’ve also heard from other sources that the registered users could be nearly double that, coming in at 50 million registered users.
These numbers are substantial for a company with a $7 million market cap. Looking ahead, it won’t be shocking if IGPK sets its sights on moving up to a bigger exchange like NASDAQ. It’s no secret they’re already in the big leagues – or it at least appears so. If that were the case, they’d of course have enhanced credibility, more visibility, and increased access to capital with institutional funding.
The App:
Now, you might be wondering, “Sounds cool, but it’s a Chinese merger with a whole setup on the other side of the planet. Can we trust this info?” @SuperRobotOTC has also gone the extra mile by downloading the app, and gave us the lowdown in video format. On top of the SEC filings, this is an added layer of trust & credibility we can attribute to this new venture. Here’s the link to the video.
Conclusion:
Fortunately it appears IGPK is still for the most part flying under the radar. There’s not even a proper website or accurate update on IGPK’s OTC Market overview to tell us what the company even entails. But here’s the silver lining – that might mean you’re still early. The intrinsic value of IGPK appears strongly disproportionate to its current value in the market.
Our advice? Keep a close eye on IGPK’s journey as it takes on this exciting phase of growth and exploration. It’s likely this story will catch wind quickly and it could be a great time to take advantage. As @SuperRobotOTC eluded to in his video, this could be the OTC’s largest merger, with a potential $70B valuation.
We will update you on IGPK when more details emerge, subscribe to Microcapdaily to follow along!
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.
Picture by geralt from Pixabay
Recent Posts
Clean Vision Corp (OTC: CLNV): Overcoming the Plastic Waste Crisis
Meta Materials (NASDAQ: MMAT): More Due Diligence and Exploring Latest Developments
Integrated Cannabis Solutions’ (OTC: IGPK) 633% Surge: Exploring Catalysts, Company Overview, and Growth Potential in 2024
Sonoma Pharmaceuticals (NASDAQ: SNOA): Potential Surge to Speculations – What Lies Ahead?
1847 Holdings (NYSE: EFSH) Soars: Insights, Acquisitions, and What Lies Ahead
Trending
-
Uncategorized2 years ago
Meta Materials Inc (OTCMKTS: MMTLP) Enormous Short Position in Trouble as Next Bridge Hydrocarbons Set to Stop Trading (George Palikaras & John Brda on Corporate Action)
-
Micro Cap Insider3 years ago
Medium (KOK PLAY) The Parabolic Rise of Metal Arts (OTCMKTS: MTRT)
-
Media & Technology4 years ago
Healthier Choices Management Corp. (OTCMKTS: HCMC) Powerful Comeback Brewing as PMI Patent Infringement Lawsuit Moves Forward
-
Media & Technology4 years ago
AMECA Mining RM; the Rise of Southcorp Capital, Inc. (OTCMKTS: STHC)
-
BioPharma3 years ago
Asia Broadband (OTCMKTS: AABB) On the Move Northbound Since Sub $0.08 Dip as Crypto Innovator Elevates AABB Crypto Exchange & Enters the NFT Space
-
Media & Technology3 years ago
SNPW (Sun Pacific Holding Corp) Power Brewing: 50MW solar farm project in Durango Mexico MOU with Atlas Medrecycler 48,000 SF New Partnership Queensland Australia Solar Farm.
-
Uncategorized2 years ago
Meta Materials Inc (OTCMKTS: MMTLP) Short Squeeze S-1a4 Filing Signals S1 Approval Could Be Days Away (Next Bridge Hydrocarbons Spin-Off)
-
BioPharma3 years ago
Humbl Inc (OTCMKTS: HMBL) Major Reversal as Powerful Advisor Rejoins the Team & Looks to Uplist to Major Exchange